GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 266 filers reported holding GENOMIC HEALTH INC in Q1 2019. The put-call ratio across all filers is 1.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $7,859,000 | +22.1% | 115,880 | +4.7% | 0.43% | +35.8% |
| Q2 2019 | $6,439,000 | -22.0% | 110,689 | -6.1% | 0.32% | -28.2% |
| Q1 2019 | $8,258,000 | -1.9% | 117,882 | -9.8% | 0.44% | -25.7% |
| Q4 2018 | $8,415,000 | +1717.5% | 130,650 | +1879.5% | 0.60% | +2284.0% |
| Q3 2018 | $463,000 | – | 6,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 10,198,943 | $714,436,000 | 4.57% |
| Crosspoint Capital Strategies, LLC | 18,815 | $1,318,000 | 2.38% |
| Copper Rock Capital Partners, LLC | 331,205 | $22,890,000 | 1.66% |
| EMORY UNIVERSITY | 28,619 | $2,005,000 | 1.41% |
| Texas Children's | 11,967 | $838,000 | 1.02% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 185,425 | $12,989,000 | 0.99% |
| DE BURLO GROUP INC | 58,100 | $4,070,000 | 0.82% |
| Capital Impact Advisors, LLC | 24,665 | $1,570,000 | 0.70% |
| Neo Ivy Capital Management | 14,774 | $1,034,000 | 0.59% |
| NEXT CENTURY GROWTH INVESTORS LLC | 54,398 | $3,810,000 | 0.51% |